retatrutide type 2 diabetes trial Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA Phase 2 Trial of Retatrutide

Methemoglobin - it's not just blue: a concise review

Metabolic Disorders: It is being investigated for its role in managing conditions such as obesity and diabetes, helping to optimize fat metabolism and energy utilization

Elure R, Offner N, Varlet I, Motteux O, Signon L et al (2007) Compartmentalization of the functions and regulation of the mitotic cyclin Clb2 in S

Decreases adipocytes and produces collagen to increase skin elasticity

In OVX rat models, Aucubin suppresses the MAPK/NF-B pathway and preserves pre-osteoclasts, thereby promoting PDGF-BBmediated Type H vessel formation and improving bone microarchitecture ( PNS activate the PI3K/Akt/mTOR pathway and upregulate multiple angiogenic mediators, including VEGF , Ang-1 , VEGFR2 , and Angiopoietin-like protein 2 (ANGPTL2)